news release

Xevant Announces Key Additions to Its Executive Leaderships Team

DRAPER, Utah, Sept. 21, 2021 (GLOBE NEWSWIRE) — Xevant, the leader and creator of automated data analytics for pharmacy benefits organizations, announced the additions of Jason Hardin, Jeff Lininger, and Lokendra Upadhyay as Xevant’s CRO, COO, and VP of Product Development, respectively. 

With 20+ years of sales and sales management experience in SaaS sales and professional services, Jason is a dynamic, performance-driven leader with an exceptional record of achievement in motivating sales teams to exceed quotas, while ensuring client success. 

Jason’s experience in managing teams and selling SaaS solutions over the past 15+ years has led to increasing combined valuations of $500M. “It’s an exciting time to join Xevant with its current state of growth. I look forward to leading such a passionate team,” Jason stated.

Prior to joining Xevant, Jeff Lininger successfully applied his extensive, multidisciplinary expertise in building and scaling growth and service infrastructures within start-up, mid-market, and Fortune 500 technology and services companies. Jeff holds an MBA from Duke University’s Fuqua School of Business in North Carolina and a Bachelor’s Degree in Finance and Economics from Grove City College in Pennsylvania. Lininger said, “I’m thrilled to join the Xevant team and look forward to contributing to a culture already set for success.”

Lokendra Upadhyay is a PharmD with nearly 27 years of varied pharmacy experience and is well-versed in utilization trends and cost mitigation strategies in the areas of traditional and specialty medications. As an advocate of educating physicians, patients, and pharmacists by leveraging data, Lokendra said he “couldn’t be happier to join such an innovative company that is capable of a more targeted outreach.” 

Xevant CEO, Brandon Newman added, “Jason’s experience in sales, client success, and business development will enable us to penetrate new markets, achieve adoption and retention goals, and grow market share and revenue quickly.” He continued, “The additions of Jeff and Lokendra will play a pivotal role in scaling and building the company for even further growth. We’re excited to bring them both onboard and confident their combined expertise will lead us to further operational excellence.”

Xevant

Blog Sign up

Subscribe to our blog and receive the latest Xevant news and updates.

Name
This field is for validation purposes and should be left unchanged.

Laura Phillipson

Director, Client Success

Laura Phillipson is a client management expert with experience managing client services teams. Her past roles include Sr. Client Services Executive for Navitus and over a decade of experience as a Certified Pharmacy Technician. Laura’s career in client relations spans nearly two decades. An avid sports fan, Laura excels in helping clients create a strong strategy with a competitive edge. Laura’s extensive background in both customer service and the medical field provides an ideal blend to lead client management for Xevant.

Download our Drug Trend Report

Discover how key drivers of drug costs are impacting overall change. This report analyzes Drug Inflation, Drug Mix, PBM Discounts, Utilizer Changes,  and Quantity Changes.

Name(Required)
This field is for validation purposes and should be left unchanged.